title: Quiescent posterior capsule trauma after intravitreal injection: implications for the cataract surgeon.
authors.forename: Yousuf M
authors.initials: YM
authors.lastname: Khalifa
authors.forename: Seth M
authors.initials: SM
authors.lastname: Pantanelli
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002386:Cataract / Q000209:etiology; D002387:Cataract Extraction; D015807:Eye Injuries, Penetrating / Q000175:diagnosis* / Q000209:etiology; D006801:Humans; D058449:Intravitreal Injections; D008268:Macular Degeneration / Q000188:drug therapy; D008297:Male; D016602:Needlestick Injuries / Q000150:complications / Q000175:diagnosis*; D057852:Posterior Capsule of the Lens / Q000293:injuries* / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014945:Wound Healing
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab